약물 내성 감염에 대한 새로운 항생제의 합리적 설계
Nature Asia ,
리서치 하이라이트 2021년9월30일 Nature 597, 7878 베타-락탐 항생제 사용의 주요 장애물은 ESBL (Extended-spectrum β-lactamases)의 유병률 증가와 BLI (β-lactamase…
리서치 하이라이트 2021년9월30일 Nature 597, 7878 베타-락탐 항생제 사용의 주요 장애물은 ESBL (Extended-spectrum β-lactamases)의 유병률 증가와 BLI (β-lactamase…
리서치 하이라이트 2021년9월30일 Nature 597, 7878 베타-락탐 항생제 사용의 주요 장애물은 ESBL (Extended-spectrum β-lactamases)의 유병률 증가와 BLI (β-lactamase…
Jason Mast Editor About four years ago, Ruben Tommasi, the gregarious scientific chief of antibiotics startup Entasis…
By: GlobenewsWire - 15 Sep 2021 Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
GlobeNewswire 2021-09-15 Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and…
Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against Multidrug-Resistant…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company…
In this article: Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Holdings Inc. (NASDAQ:), a clinical-stage biopharmaceutical company focused…
WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company…